$0.961
-0.172 (-17.90%)At close
MEDS News
MEDS Events
Wall Street Major Indices Close Slightly Lower on Monday
Wall Street's major stock indexes closed fractionally lower Monday as investors awaited a heavy retail earnings slate, including Home Depot, Target, and Walmart, while geopolitical tensions and shifting Fed expectations also weighed on sentiment. The Dow Jones Industrial Average dipped about 0.3%, while the S&P 500 slipped 0.1%, and the Nasdaq Composite was slightly higher.Most economists expect the Fed to hold rates at 3.5%–3.75% through year-end, as weaker July employment, softer inflation and declining retail sales have reduced expectations for a September hike, though elevated inflation keeps a hike later in the year possible. The dollar fell to a 10-week low, reflecting doubts over whether the Federal Reserve will raise interest rates this year.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Equinoragreed toin the Lackawanna Energy Center for $940MNvidiawillin SB Energy for its Ohio data center leased to OpenAIOmniAbentered a globalwith Eli Lilly and Companythat Commerce Secretary Howard Lutnick said the White House does not want Appleto buy memory chips from ChinaArrow Electronicsexpanded its IBMdistribution coverage to2. WALL STREET CALLS:DeutscheSentinelOneto Hold following the stock's 90% rally from April lowsJefferiesof Honeywellwith a Hold ratingWorkdayto Hold at BTIG, with the firm noting shares are "priced for a buyout"CAEto Outperform at RBC CapitalPennyMac Mortgageto Buy at Deutsche, with the firm calling the recent selloff "overdone"3. AROUND THE WEB:In a recently published report, Wolf Pack said it is short Flotek (FTK) as the company has "yet to disclose to investors that their $400 million contract with the Puerto Rico Electrix Power Authority, accounting for about 57% of FTK's backlog, has been canceled."Alibabais set to sell its entire stake in Lingxi Games to Trustar Capital for more than $2B, advancing its strategy of divesting non-core assets to focus capital and management attention on AI and cloud computing, Reuters reportsAmazonis buying huge quantities of rare books, scanning them for AI, and destroying them, 404 Media reportsNexGen Energyis sharing information and talking regularly with BHP Groupabout its Rook I mining project in Saskatchewan, CEO Leigh Curyer told ReutersTeslahas told staff it is planning for a public Cybercab launch in August, its first vehicle without a steering wheel or brake pedal, Information reports4. MOVERS:Hive Digitalincreases afterGPU cloud services pact with an enterprise customerH Worldincreases in New York afterEnovixfalls after announcing theRaj TalluriEyePointlower after announcing its Duravyu Phase 3 studyGeminideclines after Goldman Sachs, Needham, Mizuho, Rosenblatt, and Cantor Fitzgeraldon the stocks following Q2 results5. EARNINGS/GUIDANCE:Bally'swith CEO commenting, "We delivered solid second quarter results across the enterprise"InspireMD, with EPS and revenue missing consensusPioneer Power, with EPS and revenue lower year-over-yearCEL-SCI, with CEO Geert Kersten commenting, "This was a quarter of important progress across our clinical, regulatory and commercialization programs as we move Multikine closer to patients"DataMEDS AI, with EPS and revenue lower year-over-yearINDEXES:The Dow was down 272.63, or 0.51%, to 53,459.78, the Nasdaq was down 84.25, or 0.32%, to 26,644.91, and the S&P 500 was down 40.70, or 0.52%, to 7,745.06.
Wall Street Slightly Lower as Retail Earnings Awaited
Wall Street traded slightly lower Monday as investors awaited a heavy retail earnings slate, including Home Depot, Target, and Walmart, while geopolitical tensions and shifting Fed expectations also weighed on sentiment. The Dow Jones Industrial Average dipped about 0.3%, while the S&P 500 slipped 0.1%, and the Nasdaq Composite was slightly higher.Most economists expect the Fed to hold rates at 3.5%–3.75% through year-end, as weaker July employment, softer inflation and declining retail sales have reduced expectations for a September hike, though elevated inflation keeps a hike later in the year possible. The dollar fell to a 10-week low, reflecting doubts over whether the Federal Reserve will raise interest rates this year.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Equinoragreed toin the Lackawanna Energy Center for $940MNvidiawillin SB Energy for its Ohio data center leased to OpenAIOmniAbentered a globalwith Eli Lilly and Companythat Commerce Secretary Howard Lutnick said the White House does not want Appleto buy memory chips from ChinaArrow Electronicsexpanded its IBMdistribution coverage to2. WALL STREET CALLS:DeutscheSentinelOneto Hold following the stock's 90% rally from April lowsJefferiesof Honeywellwith a Hold ratingWorkdayto Hold at BTIG, with the firm noting shares are "priced for a buyout"CAEto Outperform at RBC CapitalPennyMac Mortgageto Buy at Deutsche, with the firm calling the recent selloff "overdone"3. AROUND THE WEB:Alibabais set to sell its entire stake in Lingxi Games to Trustar Capital for more than $2B, advancing its strategy of divesting non-core assets to focus capital and management attention on AI and cloud computing, Reuters reportsTo overhaul its Whopper, Burger Kingchanged up some of the ingredients and also hired U.S. Head Chef Amy Alarcon, the corporate chef who previously helped revamp Popeyes, WSJ saysAmazonis buying huge quantities of rare books, scanning them for AI, and destroying them, 404 Media reportsMastercardcard payments were temporarily declined on Saturday afternoon for Australian customers due to a global issue that has been resolved, Bloomberg saysNexGen Energyis sharing information and talking regularly with BHP Groupabout its Rook I mining project in Saskatchewan, CEO Leigh Curyer told Reuters4. MOVERS:Almontygains after announcing aof up to $300MH Worldincreases afterEnovixfalls after announcing theRaj TalluriEyePointlower after announcing its Duravyu Phase 3 studyGeminideclines after Goldman Sachs, Needham, Mizuho, Rosenblatt, and Cantor Fitzgeraldfollowing Q2 results5. EARNINGS/GUIDANCE:Bally's, with CEO commenting, "We delivered solid second quarter results across the enterprise"InspireMDwith EPS and revenue missing consensusPioneer Powerwith EPS and revenue lower year-over-yearCEL-SCIwith CEO Geert Kersten commenting, "This was a quarter of important progress across our clinical, regulatory and commercialization programs as we move Multikine closer to patients"DataMEDS AI, with EPS and revenue lower year-over-yearINDEXES:Near midday, the Dow was down 0.3%, or 184.62, to 53,547.79, the Nasdaq was up 0.2%, or 43.74, to 26,772.10, and the S&P 500 was down 0.1%, or 8.53, to 7,777.23.
Company Reports Q2 Revenue of $1.78M
Reports Q2 revenue $1.78M…
DataMeds AI Updates Corexa Pharmacy Developments
DataMeds AI provided an update on the Company's pharmaceuticals-focused subsidiary Corexa Health's pharmacy division Corexa Pharmacy. The company said, "Corexa Pharmacy recently achieved several qualitative and quantitative milestones that position it to be the centerpiece of Company growth in the 2H26. Registration with TrumpRx to be able to offer patients access to oral GLP-1 agonist drugs, such as Eli Lilly's Foundayo and Novo Nordisk's oral Wegovy, for as little as $149 out of pocket costs. Injectable GLP-1 agonist drugs are also now available. Availability of GLP-1 agonist companion medical food Forzet, manufactured by Tollo Health, LLC, to complement patients' use of GLP-1 agonist drugs for the dietary management of muscle loss associated with weight loss therapies. Launch of online store CorexaRx.com/Store. Integration of CorexaRx.com/Store into the Health Lives Here app that was recently introduced at the 2026 Pro Football Hall of Fame Game initially exclusively for former NFL players allowing patients to conduct a telemedicine visit and be prescribed and/or refill a GLP-1 agonist drug as well as Forzet, and monitor health data over time while on therapy. The Health Lives Here app is expected to launch to the public in September, with a staged state by state rollout beginning in North Carolina. Availability of Tollo Health medical food Galectovid and dietary supplement Tollovid targeting customers with acute and chronic viral infections. Availability of other dietary supplements to allow customers to order their suite of nutraceuticals from Corexa Pharmacy alongside their medications. Portfolio expansion to non-GLP-1 agonist pharmaceutical drugs in order to dispense drugs to patients prescribed GLP-1 agonist drugs, as well as medications for other conditions. July 2026 revenue exceeded $600,000, stabilizing Corexa Pharmacy's run rate above $7M annually as the Company prepares to benefit from the initiation of a former NFL player-led influencer campaign to drive downloads, physician visits, GLP-1 agonist drug prescriptions and sales of companion product Forzet through the Health Lives Here app, marketed together with NFL Alumni Health"
DataMeds AI Completes Name Changes of Subsidiaries
DataMeds AI announced that it has completed the name changes of its pharmacy and pharmacy hub subsidiaries to Corexa Pharmacy and Corexa Tech & Hub, respectively. Corexa Pharmacy and Corexa Hub are themselves subsidiaries of the Company's newly renamed pharmacy-focused division Corexa Health. The effort to create a different naming structure for the parent holding company DataMeds AI, Inc. from its operating subsidiaries that are focused on different areas of healthcare is aimed at creating a structure that allows for the vertical integration of healthcare delivery services to patients. The Company's nationally-licensed pharmaceutical distribution-focused subsidiary will currently remain Wellgistics.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.
